IgE (Omalizumab Biosimilar) Anticorps
(IgE (Omalizumab Biosimilar))
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
IgE (Omalizumab Biosimilar) recommandé Anticorps
Dernières publications sur nos produits IgE (Omalizumab Biosimilar)
: "Optimisation of omalizumab dosage in patients with severe persistent allergic asthma using recoveryELISA." dans: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, Vol. 28, Issue 5, pp. 445-50, (2014) (PubMed).: "Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22." dans: Current medical research and opinion, Vol. 30, Issue 10, pp. 1923-5, (2014) (PubMed).
: "The recovery-ELISA--a novel assay technique to monitor therapy with humanized antibodies: the example of omalizumab." dans: Journal of immunoassay & immunochemistry, Vol. 34, Issue 1, pp. 83-93, (2013) (PubMed).
: "The recoveryELISA--a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy." dans: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 50, Issue 7, pp. 1263-9, (2012) (PubMed).
: "Monitoring free serum IgE in severe asthma patients treated with omalizumab." dans: Respiratory medicine, Vol. 106, Issue 11, pp. 1494-500, (2012) (PubMed).